UW has begun treating patients with donanemab, a new Alzheimer’s medication that may slow cognitive decline in people with early-stage disease.

The second U.S. drug shown to slow the progression of early Alzheimer's has arrived in Seattle-area clinics. One of the first ...

When the NIH canceled grants in March related to diversity, equity and inclusion, or DEI, some Alzheimer’s studies were swept ...

A freeze of NIH funding threatens research into aging and Alzheimer’s at the UW School of Medicine. By David Marcinek, Jessica Young, Suman Jayadev, Thomas Grabowski and C. Dirk Keene / For The Herald ...

Richard “Marcy” Price, a former Hunt Valley real estate office manager who won All-American lacrosse honors in 1962, died ...

“The NIH decision to restrict access to key genomic and medical datasets hinders global cooperation at a time when coordinated action is needed”, said Anjee Davis (Fight Colorectal Cancer, Springfield ...

Illinois Lieutenant Governor Juliana Stratton is making a move for higher office. On Thursday, she announced her bid for the ...

SEATTLE — There's new hope for people in the early stages of Alzheimer's disease. A new medication called donanemab appears ...